Ankur Dhingra serves as the Chief Financial Officer of Illumina, Inc., a leading genomics company, a position he has held since February 2021. In this role, he oversees the company's global financial operations, including financial planning and analysis, treasury, tax, investor relations, and corporate development. Dhingra plays a pivotal role in driving Illumina's financial strategy amid rapid advancements in genomic sequencing technologies, supporting initiatives like cost optimization, capital allocation, and navigating complex regulatory landscapes, such as the ongoing developments surrounding the Grail acquisition. Prior to joining Illumina, Dhingra was CFO at Veeva Systems from 2017 to 2021, where he helped scale the cloud-based software provider for the life sciences industry, growing annual revenue from approximately $500 million to over $1.5 billion while strengthening its position as a public market leader. His earlier career included senior finance leadership roles at Salesforce.com, rising to Vice President of Finance for Enterprise Sales and managing director in strategic finance, contributing to the company's explosive growth during its early public years. Dhingra began his professional journey as a consultant at Bain & Company, honing his expertise in strategy and operations. A Stanford University alumnus with a B.S. in Electrical Engineering, Dhingra also earned an MBA from Harvard Business School. His achievements include multiple recognitions for financial leadership, such as being named one of the "Best Finance Leaders" by the San Francisco Business Times, and he has been instrumental in fostering sustainable growth and shareholder value across high-tech and biotech sectors.